An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors

Clinical trial NCT06915727 · RECRUITING

Trial details

NCT number: NCT06915727
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Childhood Malignant Solid Neoplasm Childhood Malignant Thoracic Neoplasm Malignant Abdominal Neoplasm Malignant Neck Neoplasm Malignant Pelvic Neoplasm Metastatic Childhood Malignant Solid Neoplasm

Start date: 2025-04-15
Primary completion: 2027-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.